PI
REGN icon

PEAK6 Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

PEAK6 Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.73K Hold
2
– – ﹤0.01% 3314
2024
Q2 		$2.19K Hold
2
– – ﹤0.01% 3380
2024
Q1 		$1.6K Buy
2
+1
+100% +$951 ﹤0.01% 3830
2023
Q4 		$1.27K Sell
1
-2
-67% -$1.65K ﹤0.01% 4041
2023
Q3 		$2.29K Buy
3
+1
+50% +$786 ﹤0.01% 3900
2023
Q2 		$1.48K Sell
2
-1
-33% -$771 ﹤0.01% 3752
2023
Q1 		$2.72K Sell
3
-454
-99% -$342K ﹤0.01% 4044
2022
Q4 		$330K Buy
457
+453
+11,325% +$334K ﹤0.01% 2876
2022
Q3 		$2K Buy
4
+2
+100% +$1.26K ﹤0.01% 4732
2022
Q2 		$1.48K Hold
2
– – ﹤0.01% 3753
2022
Q1 		$1K Sell
2
-8,744
-100% -$5.53M ﹤0.01% 5062
2021
Q4 		$5.52M Sell
8,746
-2,124
-20% -$1.31M 0.01% 1067
2021
Q3 		$6.58M Buy
10,870
+9,690
+821% +$6.02M 0.01% 965
2021
Q2 		$659K Sell
1,180
-25,169
-96% -$12.8M ﹤0.01% 2988
2021
Q1 		$12.5M Buy
26,349
+24,647
+1,448% +$12M 0.03% 527
2020
Q4 		$822K Buy
+1,702
New +$919K ﹤0.01% 2664
2019
Q4 		– Sell
-4,750
Closed -$1.6M – 3927
2019
Q3 		$1.32M Sell
4,750
-33,511
-88% -$9.92M 0.01% 1561
2019
Q2 		$12M Buy
38,261
+33,447
+695% +$11.1M 0.08% 299
2019
Q1 		$1.98M Sell
4,814
-7,571
-61% -$3.12M 0.01% 1315
2018
Q4 		$4.63M Buy
+12,385
New +$4.53M 0.03% 690

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PEAK6 Investments's REGN Position: Q3 2024 in Review

PEAK6 Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 2 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

PEAK6 Investments first reported a position in REGN in Q4 2018 and has held it in 20 quarters since. The position peaked at $12.5M in Q1 2021. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • PEAK6 Investments held 2 shares of Regeneron Pharmaceuticals worth $1.73K as of Q3 2024.
  • PEAK6 Investments left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
  • Regeneron Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3314 holding.
  • PEAK6 Investments first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's Regeneron Pharmaceuticals position peaked at $12.5M in Q1 2021.
  • 1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.